Paperpal Prime Logo

Medical Oncology : Impact Factor & More

eISSN: 1559-131XpISSN: 1357-0560

Key Metrics

CiteScore
5.1
H-Index
87
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.98
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Medical Oncology

Medical Oncology Journal Specifications

Overview
Publisher HUMANA PRESS INC
Language English
Frequency Continuous publication
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year1984
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Medical Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Medical Oncology

Iron oxide nanoparticles co-conjugated with hyaluronic acid and limonene trigger oxidative stress and cell cycle arrest in triple-negative breast cancer.
  • 7 Aug 2026
  • Medical oncology (Northwood, London, England)
Current status and challenges of immune checkpoint inhibitors in liver cancer: from monotherapy to combination strategies.
  • 7 Aug 2026
  • Medical oncology (Northwood, London, England)
Genomic, transcriptomic, and molecular predictors of response to neoadjuvant therapy in locally advanced rectal cancer: a narrative review.
  • 7 Aug 2026
  • Medical oncology (Northwood, London, England)
Survivin mRNA lipid nanoparticles and CTLA-4 inhibitor co-delivery activates anti-tumor cytotoxic T-lymphocytes for oral cancer immunotherapy.
  • 7 Aug 2026
  • Medical oncology (Northwood, London, England)
Mesenchymal stromal cells regulate M2 macrophage polarization that promotes proliferation, migration, and invasion of renal cell carcinoma cells.
  • 7 Aug 2026
  • Medical oncology (Northwood, London, England)
Development and validation of a nomogram for predicting venous thromboembolism risk in colorectal cancer patients undergoing postoperative chemotherapy.
  • 7 Aug 2026
  • Medical oncology (Northwood, London, England)
Iron oxide nanoparticles co-conjugated with hyaluronic acid and limonene trigger oxidative stress and cell cycle arrest in triple-negative breast cancer.
  • 7 Aug 2026
  • Medical oncology (Northwood, London, England)
Current status and challenges of immune checkpoint inhibitors in liver cancer: from monotherapy to combination strategies.
  • 7 Aug 2026
  • Medical oncology (Northwood, London, England)
Genomic, transcriptomic, and molecular predictors of response to neoadjuvant therapy in locally advanced rectal cancer: a narrative review.
  • 7 Aug 2026
  • Medical oncology (Northwood, London, England)
Survivin mRNA lipid nanoparticles and CTLA-4 inhibitor co-delivery activates anti-tumor cytotoxic T-lymphocytes for oral cancer immunotherapy.
  • 7 Aug 2026
  • Medical oncology (Northwood, London, England)
Mesenchymal stromal cells regulate M2 macrophage polarization that promotes proliferation, migration, and invasion of renal cell carcinoma cells.
  • 7 Aug 2026
  • Medical oncology (Northwood, London, England)
Development and validation of a nomogram for predicting venous thromboembolism risk in colorectal cancer patients undergoing postoperative chemotherapy.
  • 7 Aug 2026
  • Medical oncology (Northwood, London, England)

FAQs on Medical Oncology